Bioengineered Skin Substitutes (e.g., Apligraf, Dermagraft)

Type: device

Status: FDA Approved

Developer: Organogenesis, Inc. (Apligraf), Advanced Biohealing (Dermagraft)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026